Shankar Lal Rampal Dye-Chem Ltd

  • BSE Code : 542232
  • NSE Symbol : SRD
  • ISIN : INE01NE01012
  • Industry :TRADING

up-arrow 59.93 -0.10(-0.17%)

Open Price ()

59.00

Prev. Close ()

60.03

Volume (No’s)

30,230

Market Cap ()

383.35

Low Price ()

59.00

High Price ()

64.49

 

Board Meetings

Start Date End Date Purpose
05-Nov-2025 13-Nov-2025 Shankar Lal Rampal Dye-Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Matters including financial result for quarter ended 30 september 2025 and allied as provided in the pdf as attached. Board in its meeting considered and approved financial result for quarter and half year ended 30/09/2025. Please read attached PDF for allied approvals and detailed financial results. (As per BSE Announcement dated on: 13.11.2025)
22-Aug-2025 30-Aug-2025 Shankar Lal Rampal Dye-Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2025 inter alia to consider and approve Various Agenda including finalization of Board report convening of AGM recommendation of Final Dividend etc. as stated in pdf attached. Please read attached pdf for details. (As Per BSE Announcement Dated on: 30/08/2025)
18-Jul-2025 28-Jul-2025 Shankar Lal Rampal Dye-Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve Please find the attached documents Further to our intimation letters dated 18th July,2025; the Board of Directors have inter alia considered, noted, approved and accepted the matters attached in the pdf. Please read the pdf for detail Please find attached the pdf for detail (As per BSE Announcement Dated on 28/07/2025)
08-May-2025 19-May-2025 Shankar Lal Rampal Dye-Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve i. To consider and approve Audited Financial Statement/Results along with Cash Flow Statement & Related party Transactions as on such date and Notes to the Account for the Quarter and year ended on 31st March 2025. ii. To consider and approve the Audit report of the Statutory Auditor and allied reports for the Quarter and year ended on 31st March 2025. iii. To consider and take note on record the Annual secretarial Compliance Report of the company for the financial year ended 31st March 2025. iv. Noting of Minutes of Committees their recommendation and review of all their decision. v. Noting of various disclosures under SEBI Regulations Companies Act and other applicable w.r.t the previous year and the Current Year. vi. Any other matter as considered necessary by the chairman. Please read the attached PDF for details Further to our intimation letters dated 8th May, 2025; the Board of Directors have inter alia considered, noted, approved and accepted the matters provided in attached PDF (As Per BSE Announcement dated on 19.05.2025)
27-Mar-2025 27-Mar-2025 The Board of Directors have inter alia considered, noted, approved and accepted the following matters, namely:- 1. Renewal of Working Capital Facility to 200 million along with derivative facility from ICICI Bank; Overall facility is renewed to INR 225 Million (including 25 Million Derivative Facility). 2. Noting of Committees Minutes and Decisions. The meeting was commenced at 05:50 PM. as and concluded at 06:10 PM.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew